批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2022/05/27 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC) |
N/A
|
|
|
2020/11/03 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/02/21 |
SUPPL-17(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/12/10 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/05/22 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2004/03/01 |
SUPPL-1(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/07/18 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:CIPROFLOXACIN; DEXAMETHASONE 剂型/给药途径:SUSPENSION/DROPS;OTIC 规格:0.3%;0.1% 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021537 |
001 |
NDA |
CIPRODEX |
CIPROFLOXACIN; DEXAMETHASONE |
SUSPENSION/DROPS;OTIC |
0.3%;0.1% |
Prescription |
Yes |
Yes |
AB |
2003/07/18
|
SANDOZ |
205548 |
001 |
ANDA |
CIPROFLOXACIN AND DEXAMETHASONE |
CIPROFLOXACIN; DEXAMETHASONE |
SUSPENSION/DROPS;OTIC |
0.3%;0.1% |
Prescription |
No |
No |
AB |
2020/08/10
|
DR REDDYS |
210470 |
001 |
ANDA |
CIPROFLOXACIN AND DEXAMETHASONE |
CIPROFLOXACIN; DEXAMETHASONE |
SUSPENSION/DROPS;OTIC |
0.3%;0.1% |
Prescription |
No |
No |
AB |
2022/08/30
|
SUN PHARM |
215768 |
001 |
ANDA |
CIPROFLOXACIN AND DEXAMETHASONE |
CIPROFLOXACIN; DEXAMETHASONE |
SUSPENSION/DROPS;OTIC |
0.3%;0.1% |
Prescription |
No |
No |
AB |
2023/06/09
|
SENTISS |
216501 |
001 |
ANDA |
CIPROFLOXACIN; DEXAMETHASONE |
CIPROFLOXACIN; DEXAMETHASONE |
SUSPENSION/DROPS;OTIC |
0.3%;0.1% |
Prescription |
No |
No |
AB |
2024/03/22
|
AMNEAL |